Gsa Capital Partners LLP Ultragenyx Pharmaceutical Inc. Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

A detailed history of Gsa Capital Partners LLP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 11,508 shares of RARE stock, worth $522,463. This represents 0.05% of its overall portfolio holdings.

Number of Shares

11,508

Previous 15,575 26.11%

Holding current value

$522,463

Previous $640,000 0.16%

% of portfolio

0.05%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$40.21 - $59.36 $163,534 - $241,417	-4,067 Reduced 26.11%	11,508 $639,000
Q2 2024 Aug 15, 2024	BUY	$37.42 - $51.61 $188,072 - $259,391	5,026 Added 47.64%	15,575 $640,000
Q1 2024 May 03, 2024	BUY	$43.02 - $53.69 $453,817 - $566,375	10,549 New	10,549 $492,000
Q1 2023 May 12, 2023	BUY	$36.99 - $48.71 $1.01 Million - $1.33 Million	27,326 New	27,326 $1.1 Million
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $421,977 - $698,438	10,560 New	10,560 $437,000
Q2 2022 Aug 09, 2022	SELL	$45.8 - $85.4 $794,401 - $1.48 Million	-17,345 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$62.2 - $84.4 $224,231 - $304,262	-3,605 Reduced 17.21%	17,345 $1.26 Million
Q4 2021 Feb 14, 2022	BUY	$73.71 - $87.86 $1.54 Million - $1.84 Million	20,950 New	20,950 $1.76 Million
Q1 2021 May 10, 2021	SELL	$106.9 - $167.73 $329,679 - $517,279	-3,084 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$84.4 - $177.39 $260,289 - $547,070	3,084 New	3,084 $427,000
Q1 2020 May 12, 2020	SELL	$33.8 - $62.9 $342,360 - $637,114	-10,129 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$36.08 - $45.83 $78,293 - $99,451	2,170 Added 27.26%	10,129 $433,000
Q3 2019 Nov 12, 2019	BUY	$42.5 - $63.11 $338,257 - $502,292	7,959 New	7,959 $340,000
Q2 2019 Aug 06, 2019	SELL	$54.93 - $74.36 $159,297 - $215,644	-2,900 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$39.87 - $69.36 $115,622 - $201,144	2,900 New	2,900 $201,000
Q3 2018 Nov 13, 2018	SELL	$71.81 - $90.15 $759,893 - $953,967	-10,582 Closed	0 $0
Q2 2018 Aug 09, 2018	SELL	$48.54 - $85.31 $340,653 - $598,705	-7,018 Reduced 39.88%	10,582 $813,000
Q1 2018 May 11, 2018	BUY	$44.33 - $58.52 $780,208 - $1.03 Million	17,600 New	17,600 $897,000

Others Institutions Holding RARE

# of Institutions

326

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.18B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Ultragenyx Pharmaceutical Inc. Transaction History